Atectura Breezhaler 150/80 μg
Atectura Breezhaler 150/80 μg is a medicine authorised by Swissmedic under authorisation number 67597. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 September 2020 and the authorisation is valid without a time limit. ATC code R03AK14 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 67597 |
|---|---|
| Name | Atectura Breezhaler 150/80 μg |
| Full name | Atectura Breezhaler 150/80 μg, Hartkapseln mit Pulver zur Inhalation |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03AK14 |
| First authorisation | 10 September 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Atectura Breezhaler 150/80 μg, Hartkapseln mit Pulver zur Inhalation | B | 10 September 2020 |
| 2 | Atectura Breezhaler 150/160 μg, Hartkapseln mit Pulver zur Inhalation | B | 10 September 2020 |
| 3 | Atectura Breezhaler 150/320 μg, Hartkapseln mit Pulver zur Inhalation | B | 10 September 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Kapsel(n) | R03AK14 | 03.04.5. | B |
| 2 | 90 | Kapsel(n) | R03AK14 | 03.04.5. | B |
| 3 | 30 | Kapsel(n) | R03AK14 | 03.04.5. | B |
| 4 | 90 | Kapsel(n) | R03AK14 | 03.04.5. | B |
| 5 | 30 | Kapsel(n) | R03AK14 | 03.04.5. | B |
| 6 | 90 | Kapsel(n) | R03AK14 | 03.04.5. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Atectura Breezhaler 150/80 μg authorised in Switzerland?
Yes. Atectura Breezhaler 150/80 μg is authorised by Swissmedic under authorisation number 67597, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Atectura Breezhaler 150/80 μg have?
Atectura Breezhaler 150/80 μg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Atectura Breezhaler 150/80 μg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.